|
|
||||||||
Departments of 1Surgery and 2Pediatrics, and the 3Cardiovascular Research Center, University of Virginia Health System, Charlottesville, Virginia
Submitted 9 March 2006 ; accepted in final form 13 July 2006
Lung ischemia-reperfusion (I/R) injury is a biphasic inflammatory process. Previous studies indicate that the later phase is neutrophil-dependent and that alveolar macrophages (AMs) likely contribute to the acute phase of lung I/R injury. However, the mechanism is unclear. AMs become activated and produce various cytokines and chemokines in many inflammatory responses, including transplantation. We hypothesize that AMs respond to I/R by producing key cytokines and chemokines and that depletion of AMs would reduce cytokine/chemokine expression and lung injury after I/R. To test this, using a buffer-perfused, isolated mouse lung model, we studied the impact of AM depletion by liposome-clodronate on I/R-induced lung dysfunction/injury and expression of cytokines/chemokines. I/R caused a significant increase in pulmonary artery pressure, wet-to-dry weight ratio, vascular permeability, tumor necrosis factor (TNF)-
, monocyte chemoattractant protein (MCP)-1, and macrophage inflammatory protein (MIP)-2 expression, as well as decreased pulmonary compliance, when compared with sham lungs. After AM depletion, the changes in each of these parameters between I/R and sham groups were significantly attenuated. Thus AM depletion protects the lungs from I/R-induced dysfunction and injury and significantly reduces cytokine/chemokine production. Protein expression of TNF-
and MCP-1 are positively correlated to I/R-induced lung injury, and AMs are a major producer/initiator of TNF-
, MCP-1, and MIP-2. We conclude that AMs are an essential player in the initiation of acute lung I/R injury.
pulmonary transplantation; clodronate; inflammation; chemokines
This article has been cited by other articles:
![]() |
L. M. Gazoni, V. E. Laubach, D. P. Mulloy, A. Bellizzi, E. B. Unger, J. Linden, P. I. Ellman, T. C. Lisle, and I. L. Kron Additive protection against lung ischemia-reperfusion injury by adenosine A2A receptor activation before procurement and during reperfusion J. Thorac. Cardiovasc. Surg., January 1, 2008; 135(1): 156 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Forbes, M. Pickell, M. Foroughian, L.-J. Yao, J. Lewis, and R. Veldhuizen Alveolar macrophage depletion is associated with increased surfactant pool sizes in adult rats J Appl Physiol, August 1, 2007; 103(2): 637 - 645. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Gazoni, C. G. Tribble, M. Q. Zhao, E. B. Unger, R. A. Farrar, P. I. Ellman, L. G. Fernandez, V. E. Laubach, and I. L. Kron Pulmonary Macrophage Inhibition and Inhaled Nitric Oxide Attenuate Lung Ischemia-Reperfusion Injury Ann. Thorac. Surg., July 1, 2007; 84(1): 247 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Sharma, L. G. Fernandez, A. S. Awad, I. L. Kron, and V. E. Laubach Proinflammatory response of alveolar epithelial cells is enhanced by alveolar macrophage-produced TNF-{alpha} during pulmonary ischemia-reperfusion injury Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L105 - L113. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Fields, J. M. Bishai, W. Mitzner, and E. M. Wagner Effects of pulmonary ischemia on lung morphology Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L254 - L258. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |